デフォルト表紙
市場調査レポート
商品コード
1700172

いびき防止装置市場の2032年までの予測:製品タイプ、流通チャネル、エンドユーザー、地域別の世界分析

Anti-Snoring Devices Market Forecasts to 2032 - Global Analysis By Product Type, Distribution Channel, End User and By Geography


出版日
ページ情報
英文 200+ Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
いびき防止装置市場の2032年までの予測:製品タイプ、流通チャネル、エンドユーザー、地域別の世界分析
出版日: 2025年04月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、いびき防止装置の世界市場は2025年に10億米ドルを占め、予測期間中にCAGR 11.8%で成長し、2032年には21億米ドルに達すると予想されています。

いびき防止装置は、睡眠中の気流を改善することにより、いびきを軽減または除去するように設計された医療および消費者製品です。これらの機器は、気道閉塞、舌の位置不良、喉の筋肉の弛緩など、いびきの根本的な原因に対処することで機能します。一般的なものとしては、下顎前突装置(MAD)、舌保持装置(TRD)、鼻腔拡張器、持続陽圧呼吸器(CPAP)などがあります。いびきは、気道が部分的に塞がれ、喉の軟部組織が振動することで発生します。

米国睡眠協会によると、米国の成人の約5,000~7,000万人が睡眠障害を患っており、そのうち48%がいびきを訴えています。いびきは、米国では女性の40%、男性の57%が罹患していると推定されています。

睡眠障害の増加

閉塞性睡眠時無呼吸症候群や慢性いびきなどの睡眠障害は、何百万人もの人々に影響を与え、健康上の合併症や生活の質の低下につながります。これらの疾患とその長期的な影響に対する意識の高まりが、いびき防止装置の普及に拍車をかけています。睡眠の健康の重要性を啓蒙する継続的な取り組みは、睡眠障害の診断の進歩と相まって、市場成長の主要な促進要因になると予想されます。

患者のコンプライアンスの低さ

多くの患者が、不快感、不便さ、結果への不満などを理由に、これらの機器の使用を中止しています。さらに、これらの機器の適切な使用方法や長期的な利点に関する認識が不十分であることも問題を悪化させています。特に特定の人口集団や地域においては、このようなソリューションの採用に対する抵抗感が、市場への浸透を制限しています。これらの課題は、持続的な使用とコンプライアンスを確保するために、機器の設計を改善し、ユーザーを教育することの重要性を強調しています。

技術の進歩とスマートないびき防止ソリューション

モバイルアプリと統合して睡眠パターンをモニターし、フィードバックを提供するコネクテッドいびき防止装置などの製品が人気を集めています。こうした先進的なソリューションは、利便性、有効性、カスタマイズ性を高め、消費者の進化するニーズに対応しています。テクノロジーがユーザーエクスペリエンスと臨床効果のギャップを埋め続けているため、スマートデバイスの採用が市場の大幅な成長を促進すると予想されます。

手術との競合

口蓋垂口蓋咽頭形成術(UPPP)やその他の低侵襲手術などの選択肢は恒久的な解決策を提供するため、機器の長期的な需要を制限する可能性があります。高いコストと関連リスクにもかかわらず、外科的介入はより効果的であるという認識は、機器メーカーに大きな課題を突きつけています。このような競合の動きは、いびき防止装置を信頼性の高い非侵襲的な代替手段として位置づけるための絶え間ない技術革新を必要とします。

COVID-19の影響:

パンデミックは、睡眠障害の診断や管理を含むヘルスケアサービスを混乱させ、いびき防止装置市場の一時的な減速につながりました。封鎖や規制により睡眠検査や対面診察が遅れ、機器の普及率に影響を与えました。しかし、この時期には遠隔医療やバーチャル診察が台頭し、診断や治療に新たな道が開かれ、睡眠の健康に対する意識が高まりました。パンデミック後は、遠隔ヘルスケアソリューションが重視され、市場の回復力と成長軌道が強化されると予想されます。

予測期間中、下顎前突矯正装置分野が最大となる見込み

予測期間中、下顎前突矯正装置分野が最大の市場シェアを占めると予想されます。下顎前突装置は、気道開放を維持するために下顎の位置を変えることで、軽度から中等度の睡眠時無呼吸症候群やいびきの治療に非常に効果的です。その幅広い採用は、使いやすさ、非侵襲性、実証済みの臨床的有効性に起因しています。患者やヘルスケアプロバイダーの間でMADの認知度が高まるにつれ、市場の収益への貢献も大きくなると予想されます。

予測期間中、睡眠治療クリニック分野が最も高いCAGRが見込まれる

予測期間中、睡眠障害に対する意識の高まりから、睡眠治療クリニック分野が最も高い成長率を示すと予測されます。睡眠治療クリニックは、睡眠障害患者の診断検査、個人に合わせた装置の装着、フォローアップケアなどの専門的なサービスを提供しています。包括的でオーダーメイドのソリューションを提供できることから、特に専門的な指導を求める個人の間で需要が高まっています。睡眠療法インフラへの投資の増加と睡眠障害の有病率の上昇が、同分野の急速な拡大を促進すると予想されます。

最大のシェアを占める地域

予測期間中、アジア太平洋地域が最大の市場シェアを占めると予想されるのは、ヘルスケア支出の増加や中間層の急増がこの傾向に寄与しているためです。中国やインドなど、患者数が多く医療機器へのアクセスが向上している国々が主要市場として浮上しています。さらに、睡眠の健康を促進するための政府の取り組みが、この地域でのいびき防止装置の採用を促進しています。

CAGRが最も高い地域:

予測期間中、北米地域は最も高いCAGRを示すと予測されます。これは、同地域の高度なヘルスケアインフラ、睡眠障害の高い有病率、消費者の強い意識が主な要因です。さらに、継続的な技術進歩や大手市場企業の存在が、技術革新と採用を促進しています。好意的な償還政策と非侵襲的治療オプションへの嗜好の高まりが、この地域での市場成長をさらに後押しすると予想されます。

無料カスタマイズサービス:

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場企業の包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査資料
    • 1次調査資料
    • 2次調査情報源
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界のいびき防止装置市場:製品タイプ別

  • 下顎前進装置
  • 舌安定装置
  • 鼻腔デバイス
  • チンストラップ
  • 位置制御装置
  • 呼気陽圧呼吸(EPAP)装置
  • その他の製品タイプ

第6章 世界のいびき防止装置市場:流通チャネル別

  • 小売薬局
  • オンライン薬局
  • 病院薬局

第7章 世界のいびき防止装置市場:エンドユーザー別

  • 病院
  • 睡眠療法クリニック
  • 在宅ケア

第8章 世界のいびき防止装置市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイリング

  • Vyaire Medical
  • Vivos Therapeutics Inc
  • Apple
  • The Pure Sleep Company
  • SomnoMed
  • Prosomnus Sleep Technologies
  • ResMed
  • Mitsui Chemicals
  • Meditas
  • Lumenis
  • Lear Corporation
  • Koninklijke Philips N.V
  • Innovative Health Technologies
  • Illusion Aligners
  • GSK Plc
  • Fisher & Paykel Healthcare Limited
  • ASF Medical GmbH
  • Apnea Sciences
  • AccuMED
図表

List of Tables

  • Table 1 Global Anti-Snoring Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Anti-Snoring Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Anti-Snoring Devices Market Outlook, By Mandibular Advancement Devices (2024-2032) ($MN)
  • Table 4 Global Anti-Snoring Devices Market Outlook, By Tongue Stabilizing Devices (2024-2032) ($MN)
  • Table 5 Global Anti-Snoring Devices Market Outlook, By Nasal Devices (2024-2032) ($MN)
  • Table 6 Global Anti-Snoring Devices Market Outlook, By Chin Straps (2024-2032) ($MN)
  • Table 7 Global Anti-Snoring Devices Market Outlook, By Position Control Devices (2024-2032) ($MN)
  • Table 8 Global Anti-Snoring Devices Market Outlook, By Expiratory Positive Airway Pressure (EPAP) Devices (2024-2032) ($MN)
  • Table 9 Global Anti-Snoring Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 10 Global Anti-Snoring Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 11 Global Anti-Snoring Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 12 Global Anti-Snoring Devices Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 13 Global Anti-Snoring Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 14 Global Anti-Snoring Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 15 Global Anti-Snoring Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 16 Global Anti-Snoring Devices Market Outlook, By Sleep Therapy Clinics (2024-2032) ($MN)
  • Table 17 Global Anti-Snoring Devices Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 18 North America Anti-Snoring Devices Market Outlook, By Country (2024-2032) ($MN)
  • Table 19 North America Anti-Snoring Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 20 North America Anti-Snoring Devices Market Outlook, By Mandibular Advancement Devices (2024-2032) ($MN)
  • Table 21 North America Anti-Snoring Devices Market Outlook, By Tongue Stabilizing Devices (2024-2032) ($MN)
  • Table 22 North America Anti-Snoring Devices Market Outlook, By Nasal Devices (2024-2032) ($MN)
  • Table 23 North America Anti-Snoring Devices Market Outlook, By Chin Straps (2024-2032) ($MN)
  • Table 24 North America Anti-Snoring Devices Market Outlook, By Position Control Devices (2024-2032) ($MN)
  • Table 25 North America Anti-Snoring Devices Market Outlook, By Expiratory Positive Airway Pressure (EPAP) Devices (2024-2032) ($MN)
  • Table 26 North America Anti-Snoring Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 27 North America Anti-Snoring Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 28 North America Anti-Snoring Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 29 North America Anti-Snoring Devices Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 30 North America Anti-Snoring Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 31 North America Anti-Snoring Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 North America Anti-Snoring Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 33 North America Anti-Snoring Devices Market Outlook, By Sleep Therapy Clinics (2024-2032) ($MN)
  • Table 34 North America Anti-Snoring Devices Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 35 Europe Anti-Snoring Devices Market Outlook, By Country (2024-2032) ($MN)
  • Table 36 Europe Anti-Snoring Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 37 Europe Anti-Snoring Devices Market Outlook, By Mandibular Advancement Devices (2024-2032) ($MN)
  • Table 38 Europe Anti-Snoring Devices Market Outlook, By Tongue Stabilizing Devices (2024-2032) ($MN)
  • Table 39 Europe Anti-Snoring Devices Market Outlook, By Nasal Devices (2024-2032) ($MN)
  • Table 40 Europe Anti-Snoring Devices Market Outlook, By Chin Straps (2024-2032) ($MN)
  • Table 41 Europe Anti-Snoring Devices Market Outlook, By Position Control Devices (2024-2032) ($MN)
  • Table 42 Europe Anti-Snoring Devices Market Outlook, By Expiratory Positive Airway Pressure (EPAP) Devices (2024-2032) ($MN)
  • Table 43 Europe Anti-Snoring Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 44 Europe Anti-Snoring Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 45 Europe Anti-Snoring Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 46 Europe Anti-Snoring Devices Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 47 Europe Anti-Snoring Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 48 Europe Anti-Snoring Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 49 Europe Anti-Snoring Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 50 Europe Anti-Snoring Devices Market Outlook, By Sleep Therapy Clinics (2024-2032) ($MN)
  • Table 51 Europe Anti-Snoring Devices Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 52 Asia Pacific Anti-Snoring Devices Market Outlook, By Country (2024-2032) ($MN)
  • Table 53 Asia Pacific Anti-Snoring Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 54 Asia Pacific Anti-Snoring Devices Market Outlook, By Mandibular Advancement Devices (2024-2032) ($MN)
  • Table 55 Asia Pacific Anti-Snoring Devices Market Outlook, By Tongue Stabilizing Devices (2024-2032) ($MN)
  • Table 56 Asia Pacific Anti-Snoring Devices Market Outlook, By Nasal Devices (2024-2032) ($MN)
  • Table 57 Asia Pacific Anti-Snoring Devices Market Outlook, By Chin Straps (2024-2032) ($MN)
  • Table 58 Asia Pacific Anti-Snoring Devices Market Outlook, By Position Control Devices (2024-2032) ($MN)
  • Table 59 Asia Pacific Anti-Snoring Devices Market Outlook, By Expiratory Positive Airway Pressure (EPAP) Devices (2024-2032) ($MN)
  • Table 60 Asia Pacific Anti-Snoring Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 61 Asia Pacific Anti-Snoring Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 62 Asia Pacific Anti-Snoring Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 63 Asia Pacific Anti-Snoring Devices Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 64 Asia Pacific Anti-Snoring Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 65 Asia Pacific Anti-Snoring Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 66 Asia Pacific Anti-Snoring Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 67 Asia Pacific Anti-Snoring Devices Market Outlook, By Sleep Therapy Clinics (2024-2032) ($MN)
  • Table 68 Asia Pacific Anti-Snoring Devices Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 69 South America Anti-Snoring Devices Market Outlook, By Country (2024-2032) ($MN)
  • Table 70 South America Anti-Snoring Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 71 South America Anti-Snoring Devices Market Outlook, By Mandibular Advancement Devices (2024-2032) ($MN)
  • Table 72 South America Anti-Snoring Devices Market Outlook, By Tongue Stabilizing Devices (2024-2032) ($MN)
  • Table 73 South America Anti-Snoring Devices Market Outlook, By Nasal Devices (2024-2032) ($MN)
  • Table 74 South America Anti-Snoring Devices Market Outlook, By Chin Straps (2024-2032) ($MN)
  • Table 75 South America Anti-Snoring Devices Market Outlook, By Position Control Devices (2024-2032) ($MN)
  • Table 76 South America Anti-Snoring Devices Market Outlook, By Expiratory Positive Airway Pressure (EPAP) Devices (2024-2032) ($MN)
  • Table 77 South America Anti-Snoring Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 78 South America Anti-Snoring Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 79 South America Anti-Snoring Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 80 South America Anti-Snoring Devices Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 81 South America Anti-Snoring Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 82 South America Anti-Snoring Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 83 South America Anti-Snoring Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 84 South America Anti-Snoring Devices Market Outlook, By Sleep Therapy Clinics (2024-2032) ($MN)
  • Table 85 South America Anti-Snoring Devices Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 86 Middle East & Africa Anti-Snoring Devices Market Outlook, By Country (2024-2032) ($MN)
  • Table 87 Middle East & Africa Anti-Snoring Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 88 Middle East & Africa Anti-Snoring Devices Market Outlook, By Mandibular Advancement Devices (2024-2032) ($MN)
  • Table 89 Middle East & Africa Anti-Snoring Devices Market Outlook, By Tongue Stabilizing Devices (2024-2032) ($MN)
  • Table 90 Middle East & Africa Anti-Snoring Devices Market Outlook, By Nasal Devices (2024-2032) ($MN)
  • Table 91 Middle East & Africa Anti-Snoring Devices Market Outlook, By Chin Straps (2024-2032) ($MN)
  • Table 92 Middle East & Africa Anti-Snoring Devices Market Outlook, By Position Control Devices (2024-2032) ($MN)
  • Table 93 Middle East & Africa Anti-Snoring Devices Market Outlook, By Expiratory Positive Airway Pressure (EPAP) Devices (2024-2032) ($MN)
  • Table 94 Middle East & Africa Anti-Snoring Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 95 Middle East & Africa Anti-Snoring Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 96 Middle East & Africa Anti-Snoring Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 97 Middle East & Africa Anti-Snoring Devices Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 98 Middle East & Africa Anti-Snoring Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 99 Middle East & Africa Anti-Snoring Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 100 Middle East & Africa Anti-Snoring Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 101 Middle East & Africa Anti-Snoring Devices Market Outlook, By Sleep Therapy Clinics (2024-2032) ($MN)
  • Table 102 Middle East & Africa Anti-Snoring Devices Market Outlook, By Homecare (2024-2032) ($MN)
目次
Product Code: SMRC29075

According to Stratistics MRC, the Global Anti-Snoring Devices Market is accounted for $1.0 billion in 2025 and is expected to reach $2.1 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Anti-snoring devices are medical and consumer products designed to reduce or eliminate snoring by improving airflow during sleep. These devices work by addressing the underlying causes of snoring, such as airway obstruction, poor tongue positioning, or relaxed throat muscles. Common types include mandibular advancement devices (MADs), tongue-retaining devices (TRDs), nasal dilators, and continuous positive airway pressure (CPAP) machines. Snoring occurs when the airway is partially blocked, leading to vibrations in the soft tissues of the throat.

According to the American Sleep Association, approximately 50-70 million US adults have a sleep disorder and out of those, 48% report snoring. Snoring is estimated to affect 40% of women and 57% of men in the US.

Market Dynamics:

Driver:

Rising prevalence of sleep disorders

Sleep disorders such as obstructive sleep apnea and chronic snoring affect millions, leading to health complications and decreased quality of life. Increased awareness about these conditions and their potential long-term effects has further fueled the adoption of anti-snoring devices. Ongoing efforts to educate the public about the importance of sleep health, coupled with advances in diagnosing sleep disorders, are expected to be a key driver of market growth.

Restraint:

Low patient compliance

Many individuals discontinue the use of these devices due to discomfort, inconvenience, or dissatisfaction with the results. Additionally, inadequate awareness about the proper usage and long-term benefits of these devices exacerbates the problem. Resistance to adopting such solutions, especially in certain demographic groups or regions, limits market penetration. These challenges underscore the importance of improving device design and educating users to ensure sustained usage and compliance.

Opportunity:

Technological advancements and smart anti-snoring solutions

Products such as connected anti-snoring devices, which integrate with mobile apps to monitor sleep patterns and provide feedback, are gaining traction. These advanced solutions offer enhanced convenience, effectiveness, and customization, catering to the evolving needs of consumers. As technology continues to bridge the gap between user experience and clinical efficacy, the adoption of smart devices is expected to drive significant growth in the market.

Threat:

Competition from Surgery

Options such as uvulopalatopharyngoplasty (UPPP) and other minimally invasive surgeries offer permanent solutions, potentially limiting the long-term demand for devices. The perception of surgical interventions as more effective, despite their higher costs and associated risks, poses a significant challenge to device manufacturers. This competitive dynamic necessitates continuous innovation to position anti-snoring devices as a reliable, non-invasive alternative.

Covid-19 Impact:

The pandemic disrupted healthcare services, including the diagnosis and management of sleep disorders, leading to a temporary slowdown in the anti-snoring devices market. Lockdowns and restrictions delayed sleep studies and in-person consultations, impacting device adoption rates. However, the rise of telemedicine and virtual consultations during this period offered new avenues for diagnosis and treatment, promoting awareness about sleep health. Post-pandemic, the emphasis on remote healthcare solutions is expected to strengthen the market's resilience and growth trajectory.

The mandibular advancement devices segment is expected to be the largest during the forecast period

The mandibular advancement devices segment is expected to account for the largest market share during the forecast period. Mandibular advancement devices are highly effective in treating mild to moderate cases of sleep apnea and snoring by repositioning the lower jaw to maintain an open airway. Their wide adoption can be attributed to their ease of use, non-invasive nature, and proven clinical efficacy. As awareness of MADs increases among patients and healthcare providers, their contribution to the market's revenue is expected to remain substantial.

The sleep therapy clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the sleep therapy clinics segment is predicted to witness the highest growth rate due to growing awareness of sleep disorders. Sleep therapy clinics provide specialized services, including diagnostic tests, personalized device fittings, and follow-up care for sleep disorder patients. Their ability to offer comprehensive and tailored solutions has driven demand, especially among individuals seeking professional guidance. Growing investments in sleep therapy infrastructure and the rising prevalence of sleep disorders are expected to propel the segment's rapid expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share attributed to increasing healthcare expenditure, and a burgeoning middle-class population contribute to this trend. Countries like China and India, with their large patient base and improving access to medical devices, are emerging as key markets. Additionally, government initiatives to promote sleep health are fostering the adoption of anti-snoring devices in the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR owing to the region's advanced healthcare infrastructure, high prevalence of sleep disorders, and strong consumer awareness are key contributors. Additionally, continuous technological advancements and the presence of leading market players drive innovation and adoption. Favorable reimbursement policies and increasing preference for non-invasive treatment options are further expected to bolster the market's growth in this region.

Key players in the market

Some of the key players in Anti-Snoring Devices Market include Vyaire Medical, Vivos Therapeutics Inc, Apple, The Pure Sleep Company, SomnoMed, Prosomnus Sleep Technologies, ResMed, Mitsui Chemicals, Meditas, Lumenis, Lear Corporation,Koninklijke Philips N.V, Innovative Health Technologies, Illusion Aligners, GSK Plc, Fisher & Paykel Healthcare Limited, ASF Medical GmbH, Apnea Sciences and AccuMED

Key Developments:

In September 2024, Apple introduced a sleep apnea detection feature for its smartwatches, utilizing accelerometer data and machine learning to identify respiratory interruptions during sleep. This innovation aims to increase awareness and encourage medical consultations for sleep disorders.

In January 2023, Vivos Therapeutics Inc. received FDA clearance for its DNA appliance, designed to treat mild-to-moderate obstructive sleep apnea (OSA) and snoring. This device represents a significant advancement in non-invasive treatment options for sleep-related breathing disorders.

Product Types Covered:

  • Mandibular Advancement Devices
  • Tongue Stabilizing Devices
  • Nasal Devices
  • Chin Straps
  • Position Control Devices
  • Expiratory Positive Airway Pressure (EPAP) Devices
  • Other Product Types

Distribution Channels Covered:

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

End Users Covered:

  • Hospitals
  • Sleep Therapy Clinics
  • Homecare

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Anti-Snoring Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Mandibular Advancement Devices
  • 5.3 Tongue Stabilizing Devices
  • 5.4 Nasal Devices
  • 5.5 Chin Straps
  • 5.6 Position Control Devices
  • 5.7 Expiratory Positive Airway Pressure (EPAP) Devices
  • 5.8 Other Product Types

6 Global Anti-Snoring Devices Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Retail Pharmacies
  • 6.3 Online Pharmacies
  • 6.4 Hospital Pharmacies

7 Global Anti-Snoring Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Sleep Therapy Clinics
  • 7.4 Homecare

8 Global Anti-Snoring Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Vyaire Medical
  • 10.2 Vivos Therapeutics Inc
  • 10.3 Apple
  • 10.4 The Pure Sleep Company
  • 10.5 SomnoMed
  • 10.6 Prosomnus Sleep Technologies
  • 10.7 ResMed
  • 10.8 Mitsui Chemicals
  • 10.9 Meditas
  • 10.10 Lumenis
  • 10.11 Lear Corporation
  • 10.12 Koninklijke Philips N.V
  • 10.13 Innovative Health Technologies
  • 10.14 Illusion Aligners
  • 10.15 GSK Plc
  • 10.16 Fisher & Paykel Healthcare Limited
  • 10.17 ASF Medical GmbH
  • 10.18 Apnea Sciences
  • 10.19 AccuMED